PegBio Co., Ltd. announced that it has obtained a filing notice from the China Securities Regulatory Commission (CSRC) dated 26 March 2026, confirming completion of filing for its H Share full-circulation plan.

The approval covers the conversion of 101.70 million unlisted domestic shares into H Shares. PegBio must complete the share conversion within 12 months of the filing date or submit updated materials to the CSRC if it intends to proceed beyond that period.

Following conversion, the company will apply to The Stock Exchange of Hong Kong Limited for listing and permission to deal in the newly issued H Shares on the Main Board.

Management stated that detailed implementation arrangements are still being finalized. Further disclosures will be made in accordance with Hong Kong Listing Rules and Inside Information provisions.

The H Share full-circulation process remains subject to subsequent procedures required by the CSRC, HKEX and other regulatory authorities. Shareholders and potential investors are advised to exercise caution when dealing in PegBio’s shares.